AIDS Drug Trial Halted in U.S. for Health Risks
From Times Staff and Wire Reports
The U.S. government on Wednesday stopped a trial of AIDS drugs aimed at finding out whether patients could take breaks from treatment, saying people were much more likely to become ill or die if they took breaks.
The trial quickly showed that patients do better when they continually take the drugs, said the National Institute of Allergy and Infectious Diseases. Patients taking the so-called drug vacations were twice as likely to develop AIDS or die, the researchers said.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
